Aclid closes $3.3 million seed funding round to advance biosecurity and compliance →

On a mission to secure the bioeconomy

Built by pioneers in biosecurity and synthetic biology.

Aclid was founded in 2021, in the wake of a pandemic and record-breaking growth of synthetic biology. Biological security was becoming essential, but we knew how hard it could be to build a strong security foundation. Aclid was inspired by a vision to make genetic engineering safer and more accessible.

Leadership Team

Get compliant and stay secure